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Integration of the numerous mechanisms that have been suggested to contribute to opti-
mization of O2 supply to meet O2 need in skeletal muscle requires a systems biology
approach which permits quantification of these physiological processes over a wide range
of length scales. Here we describe two individual computational models based on in vivo
and in vitro studies which, when incorporated into a single robust multiscale model, will
provide information on the role of erythrocyte-released ATP in perfusion distribution in
skeletal muscle under both physiological and pathophysiological conditions. Healthy human
erythrocytes exposed to low O2 tension release ATP via a well characterized signaling path-
way requiring activation of the G-protein, Gi, and adenylyl cyclase leading to increases in
cAMP. This cAMP then activates PKA and subsequently CFTR culminating in ATP release
via pannexin 1. A critical control point in this pathway is the level of cAMP which is reg-
ulated by pathway-specific phosphodiesterases. Using time constants (∼100 ms) that are
consistent with measured erythrocyte ATP release, we have constructed a dynamic model
of this pathway. The model predicts levels of ATP release consistent with measurements
obtained over a wide range of hemoglobin O2 saturations (sO2).The model further predicts
how insulin, at concentrations found in pre-diabetes, enhances the activity of PDE3 and
reduces intracellular cAMP levels leading to decreased low O2-induced ATP release from
erythrocytes.The second model, which couples O2 and ATP transport in capillary networks,
shows how intravascular ATP and the resulting conducted vasodilation are affected by local
sO2, convection and ATP degradation. This model also predicts network-level effects of
decreased ATP release resulting from elevated insulin levels.Taken together, these models
lay the groundwork for investigating the systems biology of the regulation of microvascular
perfusion distribution by erythrocyte-derived ATP.
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INTRODUCTION
The regulation of blood flow involves interplay among numerous
mechanisms including the tissue specific microvascular architec-
ture, wall shear stress and pressure (myogenic tone), and the
activity of the sympathetic nervous system. Although each of these
clearly contributes to total microvascular perfusion, these factors
alone are insufficient to regulate dynamically the precise distrib-
ution of perfusion to meet local tissue oxygen (O2) need. Such
a system requires a mechanism by which the need is detected,
quantified, and coupled to a mechanism for the alteration of O2
delivery. A number of theories have been proposed by which blood
flow can be increased in response to decreases in tissue oxygen ten-
sion including the arterioles themselves being sensitive to low O2
levels (Pittman and Duling, 1973; Duling, 1974; Jackson, 1987)
the release of vasodilatory metabolites within the tissues or vessels
(Hester, 1993), and more recently the release of nitric oxide (Jia
et al., 1996) and/or nitrite (Gladwin et al., 2004) from erythrocytes.
Although each may play a role, none provides the sensitivity and
rapid time course necessary for the precise matching of oxygen
supply with need.
One mechanism which has been the subject of significant inter-
est in recent years involves the regulated release of ATP (adeno-
sine triphosphate) from erythrocytes in response to a decrease
in hemoglobin oxygen saturation (sO2; Ellsworth et al., 1995,
2009; Jagger et al., 2001) as would result from their exposure to
a reduced oxygen tension environment. The ATP released would
bind to endothelial purinergic receptors inducing vasodilation via
the synthesis and release of endothelium-derived relaxing factors.
Experimentally, studies have established that infusion of ATP into
hamster skeletal muscle arterioles and venules, at concentrations
observed in vivo (Gonzalez-Alonso et al., 2002), induces a vasodi-
lation that is conducted upstream to feed arterioles resulting in
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increased perfusion (McCullough et al., 1997; Collins et al., 1998).
Such a mechanism would permit the erythrocyte, via a local release
of ATP, to evoke an increase in O2 supply to discrete regions of
the microvasculature enabling the dynamic changes in O2 deliv-
ery needed to meet changing local tissue oxygen needs. For this
mechanism to be effective, the amount of ATP released from ery-
throcytes needs to be directly related to the extent of hemoglobin
O2 desaturation (or decrease in sO2) that occurs when erythro-
cytes are exposed to low O2 tension (or partial pressure, PO2;
Jagger et al., 2001).
Several recent reviews (Ellsworth, 2000, 2004; Gonzalez-
Alonso, 2008; Ellsworth et al., 2009; Sprague et al., 2011) and
previous theoretical models (Arciero et al., 2008; Sprague et al.,
2010) have evaluated the impact of erythrocyte-released ATP
on microvascular flow regulation. However, a full understand-
ing of the effect of erythrocyte-derived ATP on the regulation
of O2 delivery requires quantification of the interacting physi-
ological processes over a wide range of physical length scales. To
accomplish this necessitates the incorporation of several individual
experiment-based computational models into a novel multiscale
model. Two critical components of such a dynamic model are
delineated here.
Significant progress has been made in defining the components
of a signaling pathway for ATP release from erythrocytes under
conditions of low O2 tension (Ellsworth et al., 2009). Important
elements of this pathway (see Figure 1) include activation of the
heterotrimeric G-protein Gi (Sprague et al., 2002; Olearczyk et al.,
2004a,b) and, subsequently, the activation of adenylyl cyclase (AC)
resulting in increases in intracellular cyclic adenosine monophos-
phate (cAMP; Sprague et al., 2002, 2005, 2006). This results in
activation of protein kinase A (PKA; Sprague et al., 2001) and
the cystic fibrosis transmembrane conductance regulator (CFTR;
Sprague et al., 1998). The final conduit for ATP release in response
to this stimulus has been determined to be pannexin 1 (Locovei
et al., 2006; Sridharan et al., 2010).
Recent experimental studies demonstrate that insulin, at con-
centrations observed in humans with pre-diabetes and used to
treat individuals with diabetes mellitus type 2 (type 2 diabetes),
inhibits low O2 tension-induced ATP release from human erythro-
cytes (Hanson et al., 2009). Importantly, animal studies suggest
that this defect contributes to the impaired tissue oxygenation
in pre-diabetes (Ellis et al., 2010). A critical control point in the
low O2 signaling pathway for regulated ATP release is the con-
centration of cAMP which is determined by a balance between
cAMP synthesis by adenylyl cyclase and its hydrolysis by phospho-
diesterases (PDEs). Insulin has been shown to increase hydrolysis
of cAMP via the enhancement of PDE3 activity (Hanson et al.,
2010).
Although signaling pathways similar to the one responsible for
ATP release from erythrocytes have been described previously
in other cells (Cazzaniga et al., 2008; Williamson et al., 2009),
no quantitative approach has integrated the signaling compo-
nents of low O2 tension-induced ATP release from erythrocytes
into a unified mathematical framework that would permit the
comprehensive study of its regulation. Here we present a single
compartment kinetic model of the low O2 tension-induced ATP
release pathway in human erythrocytes that incorporates para-
meters consistent with experimentally measured ATP release in
response to this stimulus in the absence (Sprague and Ellsworth,
2012) and presence (Hanson et al., 2009) of insulin. This model,
based on a previously described deterministic model of a G-
protein coupled cAMP pathway (Williamson et al., 2009), incor-
porates interactions among individual cellular components based
on our current understanding of the signaling pathway for low
O2 tension-induced ATP release. Our approach involves the use
of data obtained from experimental studies including those defin-
ing PDE3-mediated cAMP hydrolysis as a critical control point
for the regulation of low O2-induced ATP release from human
erythrocytes (Hanson et al., 2010).
In addition to our model of the intracellular ATP release path-
way, we utilized in vivo data obtained from rat skeletal muscle
to construct a realistic model of blood flow, O2 transport, and
ATP transport at the capillary network level to investigate the
impact of low O2-induced ATP release from erythrocytes on
FIGURE 1 | Illustration showing known components of the oxygen-dependent erythrocyte ATP release pathway.
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the regulation of perfusion distribution in skeletal muscle under
physiological conditions and when plasma insulin is increased.
Our model of capillary network ATP transport, although used to
obtain steady-state results in the present work, is novel in that it
is time-dependent and hence permits simulation of the dynam-
ics of this process. This model will be crucial in future studies
of microvascular flow regulation, which is an inherently dynamic
physiological process (e.g., due to temporal variations in both local
blood flow and O2 consumption rate), and will allow us to include
the ATP release dynamics from our pathway model into a larger-
scale model of flow regulation in complete networks containing
capillaries, arterioles, and venules.
Our underlying hypothesis is that the O2-dependent release
of ATP from erythrocytes is a key mechanism for the dynamic
regulation of the distribution of microvascular perfusion to meet
local tissue O2 needs in skeletal muscle. The long-term goal is
to utilize a combination of computational models and experi-
mental studies to ascertain how and under what conditions ATP
release from erythrocytes contributes to appropriate O2 deliv-
ery. Furthermore, the use of computational models provides a
mechanism by which predictions of impaired ATP release based
on known defects associated with certain disease states, and the
potential effectiveness of pharmacological interventions to res-
cue the defect, can be evaluated. Experimental data supporting
the stated hypothesis have been reported previously (Collins
et al., 1998; Dietrich et al., 2000; Sprague et al., 2009) and were
used as a basis for constructing the models. The two compo-
nents described here complement models of 3D blood-tissue
O2 transport and two-phase blood flow presented previously
and will become an important part of a multiscale simulation
required to characterize flow regulation based on ATP release from
erythrocytes.
MATERIALS AND METHODS
SIMPLIFIED MODEL OF O2-DEPENDENT Gi-ACTIVATED cAMP PATHWAY
As described above, the basic components of heterotrimeric G-
protein (GP)-activated signaling pathways involving cAMP are
well-known in many cell types including the erythrocyte. To
begin modeling the key components of the O2-dependent ery-
throcyte ATP release pathway (Figure 1), we modified a sim-
ple model of a GP-activated cAMP pathway from the liter-
ature (Williamson et al., 2009). Although the exact mecha-
nism that couples a decrease in hemoglobin saturation with
GP activation has not been fully elucidated, several studies
have linked mechanical force with activation of Gi (Li and
Xu, 2000; Wan et al., 2008; Forsyth et al., 2011). Our model
requires that the desaturation of oxyhemoglobin induces acti-
vation of Gi, identified here as the activated form of GP
(GPa). When erythrocyte Gi dissociates, the βγ subunit stim-
ulates production of cAMP (via adenylyl cyclase, AC; Sprague
et al., 2002, 2005, 2006) leading to activation of protein kinase
A (PKAi→PKAa; Sprague et al., 2001, 2006). The kinetic
equations adapted for the activation of PKA in the present
model are:
d [GPa]
dt
= kGPf [GPi] [tHb]α − kGPr [GPa] (1)
d [cAMP]
dt
= ACbase + kcAMPf [GPa]
1+ kcAMPi [PKAa] −
vPDE3 [PKAa] [cAMP]
KPDE3 + [cAMP]
(2)
d [PKAa]
dt
= kPKAf [PKAi] [cAMP]− kPKAr [PKAa] (3)
Equation 1 above describes GP activation resulting from changes
in oxyhemoglobin saturation where [tHb] is the fraction of desat-
urated Hb (in the tense or “t” state; [tHb]= 1− sO2) and the
exponent α is used to modulate the relationship between [tHb]
and GPa. Equation 2 describes cAMP production and degradation,
where ACbase represents the baseline rate of cAMP production
(in the absence of GP activation) and the vPDE3 term repre-
sents degradation of cAMP by the phosphodiesterase PDE3, a
PDE shown to regulate cAMP concentrations in the erythro-
cyte O2-dependent ATP release pathway (Adderley et al., 2010).
Here, vPDE3= v0∗PDE3rel where v0 is a baseline rate of cAMP
degradation and PDE3rel is the relative amount of PDE3 activ-
ity (assumed to be one under normal baseline conditions). The
PKAa terms on the right-hand side represent negative feedback
to either inhibit cAMP production (Sobolewski et al., 2004) or
enhance cAMP degradation (Murthy et al., 2002). Eq.3 represents
direct activation of PKA by cAMP. In all our kinetic equations,
the subscript “f” indicates the forward rate constant (e.g., kPKAf)
governing production of the species of interest, while the sub-
script “r” indicates the reverse rate constant (e.g., kPKAr) governing
degradation.
PKA/CFTR-ACTIVATED ATP RELEASE
To link the PKA activation as described in Eq. 3 to the release of
ATP, two kinetic equations are employed that describe the other
known regulatory steps in the process:
d [CFTRa]
dt
= kCFTRf [CFTRi] [PKAa]β − kCFTRr [CFTRa] (4)
FATP = kATPflux [CFTRa] (5)
where the exponent β is used to modulate the relationship between
PKA activation and CFTR activation. For simplicity it is assumed
that FATP, the release rate or flux of ATP (via pannexin 1, Sridharan
et al., 2010), is proportional to activation of CFTR. In addition to
Eqs 1–5, our model assumes conservation of GP, PKA, and CFTR:
[GPtotal] = [GPi]+ [GPa]
[PKAtotal] = [PKAi]+ [PKAa]
[CFTRtotal] = [CFTRi]+ [CFTRa]
(6)
Figure 2 shows the ATP release pathway model that was orig-
inally created using the free software package Cell Designer
(http://celldesigner.org). Solution of Eqs 1–6 was implemented
in Matlab (Mathworks, Natick, MA, USA) to allow more flexibility
in exploring the model (e.g., specifying time-dependent saturation
functions and automatically integrating and averaging results over
time). A version of our Matlab simulation code is included online
as Supplementary Material.
Parameters used in Eqs 2–3 were initially those used by
Williamson et al. (2009) with modifications to reflect the much
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FIGURE 2 | Schematic showing the components and interactions included in our dynamic model of the oxygen-dependent erythrocyte ATP release
pathway.
faster time-scale of erythrocyte ATP release (∼100 ms vs.∼10 s in,
Williamson et al., 2009) as reported for shear-induced ATP release
in microfluidic experiments (Wan et al., 2008). It is important to
recognize that available evidence suggests that shear stress applied
to human erythrocytes activates the same pathway as does expo-
sure to reduced O2 (Sprague and Ellsworth, 2012). Parameters for
Eqs 1, 4, and 5 (in particular, the exponents α and β) were then set
to represent those required for a similar time-scale, and were var-
ied to match in vitro measurements of ATP release as a function
of hemoglobin saturation (Sprague and Ellsworth, 2012) where
erythrocytes were rapidly desaturated to various sO2 values start-
ing from ∼100% sO2. Although the dynamics of O2-dependent
erythrocyte ATP release are important in vivo, no dynamic mea-
surements are currently available (Sprague and Ellsworth, 2012).
Therefore, we chose to use brief desaturation steps of fixed dura-
tion (40 ms) and varying magnitude (38–84%) to investigate the
sO2 dependence of our dynamic ATP release model. The stimula-
tion time of 40 ms was motivated by the experiments by Wan et al.
(2008) in which changes in shear needed to be longer than∼6 ms
(activation time) to produce changes in erythrocyte ATP release
while the delay time between changes in shear and changes in ATP
release was∼29 ms.
An underlying assumption in our model is that the O2-
dependent pathway does not release ATP when hemoglobin is
fully saturated with oxygen (i.e., ACbase= 0). Therefore, the sO2
dependence of the model was based on the results reported by
Sprague and Ellsworth (2012) with the measured ATP release for
98% sO2 (5.4 nmol ATP per 4× 108 erythrocytes) taken to rep-
resent full saturation which was subtracted from the ATP release
values for lower saturations. This yielded target ATP release values
of 3.1, 7.1, and 13.1 nmol ATP/4× 108 erythrocytes for 61.8, 41.3,
and 21.6% sO2, respectively. To enable the model to predict the
inhibitory effect of insulin on O2-induced ATP release, as reported
experimentally (Hanson et al., 2009, 2010), the value of PDE3rel
was adjusted to model erythrocyte ATP release upon exposure to
reduced O2 tension in the presence of levels of insulin seen in pre-
diabetes or required for the treatment of type 2 diabetes (Kanauchi
et al., 2007; Ellis et al., 2010). Again, the ATP release values were
adjusted for zero ATP release at full saturation, yielding a target
value for ATP release of 11.8 nmol ATP/4× 108 erythrocytes at
15.7% sO2 without insulin and a target value of 2.77 at 20.9%
sO2 with insulin, both determined experimentally (Hanson et al.,
2009).
COMPUTATIONAL MODEL OF O2 AND ATP TRANSPORT IN CAPILLARY
NETWORKS
Numerical simulations of steady-state O2 transport were per-
formed using an established time-dependent, finite-difference
computational model (Goldman and Popel, 1999, 2000; Ellis et al.,
2010; Sprague et al., 2010) that couples the continuum partial
differential equations describing convective transport by flowing
blood in the capillaries with equations describing O2 diffusion
and consumption in the tissue. This model incorporates both dis-
solved and hemoglobin-bound O2 in the capillaries. Transport of
O2 between the blood and tissue is described using a flux bound-
ary condition with mass transfer coefficients calculated previously
using a discrete erythrocyte model (Eggleton et al., 2000). In the
model presented here, for all O2 transport simulations, a cap-
illary network reconstructed from experimental data was used
(Fraser et al., 2012) in conjunction with hemodynamic para-
meters (erythrocyte velocity and hematocrit) determined from
in vivo measurements in the rat extensor digitorum longus (EDL)
muscle. The capillary network was discretized into 208 cylindri-
cal segments and the tissue domain surrounding the capillaries,
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which had dimensions of 84× 169× 342µm, was discretized into
632,315 computational nodes. Average capillary entrance satura-
tions (63%) and the tissue O2 consumption rate (1.5× 10−4 ml
O2/ml/s) were set based on previous experimental data (Ellis
et al., 2002). The geometric and hemodynamic data used in the
blood-tissue oxygen transport calculations, as well as the result-
ing steady-state values for capillary sO2, are included online as
Supplementary Material.
Numerical simulations of steady-state ATP transport within
the capillary network were performed using a modified form of
our time-dependent finite-difference computational model for
intravascular O2 transport (Goldman and Popel, 2000). Based
on a previously described ATP transport model (Arciero et al.,
2008), the following continuum partial differential equation was
solved for plasma ATP concentration [ATP] using the geometric,
hemodynamic, and sO2 data described above and an initial ATP
concentration of zero:
(1−HT) ∂
∂t
[ATP] = −u (1−HD) ∂
∂z
[ATP]
+HTC0 (1− C1S)− 2
R
kd [ATP] (7)
where u is the averaged cross-sectional blood velocity at any axial
location z, H D is the discharge hematocrit, H T is the tube hema-
tocrit, and R is capillary radius. As previously defined (Arciero
et al., 2008), the constants C0 and C1 are used to produce a linear
approximation to the (steady-state) ATP release rate as a function
of oxyhemoglobin saturation S, while the constant kd approxi-
mates steady-state degradation of ATP by the endothelium (see
Table 1 for parameter values). To model the effect of elevated
plasma insulin on ATP release, we decreased C0 by 50% based on
experimental measurements.
In a previously reported model for microvascular regulation
(Arciero et al., 2008), seven representative unbranched vessel
segments (artery, large arteriole, small arteriole, capillary, small
venule, large venule, vein) were included in the simulation and
the inlet [ATP] in the farthest upstream vessel (artery) was set at
0.5µM. This led to an inlet [ATP] in the capillary of approximately
0.25µM. Therefore, we used this value for inlet [ATP] in our cap-
illary network simulations. However, since this value depends on
other modeling assumptions in the work of Arciero et al. (2008),
we also considered the case where [ATP] is zero at the entrance of
our capillary network to more clearly illustrate the contribution
of erythrocyte-derived ATP in the capillary bed to plasma [ATP].
The spatial distribution of steady-state sO2 values was com-
puted for the 3D capillary network based on experimental mea-
surements of entrance sO2 and total erythrocyte supply rate in the
network. The same steady-state sO2 distribution was used for both
normal and impaired ATP release. To solve Eq. 7 for steady-state
[ATP] once steady-state sO2 values had been calculated, an arbi-
trary initial condition ([ATP]= 0) was chosen and simulations
were run until [ATP] became constant in all capillary segments.
Although the present work focuses on steady-state capillary [ATP]
distributions, our computational model is capable of simulating
changes in intravascular [ATP] for time-varying blood flow, O2
consumption rate, or erythrocyte ATP release.
Table 1 | Parameters for ATP release pathway andATP transport.
Parameter Value
ACbase 0
kcAMPf 49.5
kcAMPi 2.47
v0 101
K PDE3 1
kPKAf 60.5
kPKAr 10.0
kGPf 25.0
α 1.2
kGPr 3.36
kCFTRf 181
β 6.3
kCFTRr 11.3
kATPflux 2
GPtotal 1
PKAtotal 1
CFTRtotal 1
C0 1.4×10−9 mol/s·cm3
C1 0.891
kd 2.0×10−4 cm/s
As noted above, to have a major impact on oxygen delivery to
meet increased demand, the endothelial signal produced by ATP
released in capillaries or venules must be conducted upstream
and stimulate arteriolar dilation. Therefore, we integrated [ATP]
obtained from Eq. 7 to estimate the total dilatory signal σdilation
produced by ATP released from erythrocytes in the capillary
network:
σdilation =
208∑
i=1
[ATP]i exp
(
−L − zi
λ
)
(8)
where L is the arterio-venous length of the capillary network, and
zi is the axial location of the segment with ATP concentration
[ATP]i. The parameter λ determines the length scale of attenua-
tion of the conducted signal and is set to 1 cm based on the work
of Arciero et al. (2008) who obtained this approximate value from
highly variable (0.15–1.6 cm) experimental data (Xia and Duling,
1995). Note that in the present work, σdilation is simply used as a
measure of the dilatation signal originating in the capillaries. Since
arterioles are not included in this model, we cannot use σdilation to
change vascular diameters.
RESULTS
O2-DEPENDENT ATP RELEASE PATHWAY
Using Eqs 1–6 and parameters listed in Table 1, we simulated
the response of the O2-dependent ATP release pathway in human
erythrocytes to a 40 ms period of oxyhemoglobin desaturation
starting from an initial condition with all variables equal to zero.
Figure 3 shows the predicted dynamic response of this pathway to
a step change in sO2 from 100 to 15.7% (i.e., increase in [tHb] from
0 to 0.843) with a duration of 40 ms. Figure 3 describes a temporal
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FIGURE 3 | Dynamic behavior of our model of oxygen-dependent
erythrocyte ATP release. Hemoglobin oxygen saturation is decreased from
100 to 15.7% for 40 ms, resulting in activation of the ATP release pathway
with an initial delay in ATP release followed by a peak in ATP flux at
approximately 150 ms. The pulse of hemoglobin desaturation results in a
total release of ATP (area under ATP flux curve) that can be compared to
experimental measurements. The ATP release delay and peak times are
consistent with shear-dependent release dynamics measured by Wan et al.
(2008), and the GP activation time-scale is consistent with the
measurements of Hein et al. (2005).
relationship among the components of the signaling pathway in
which GP is activated first by hemoglobin desaturation with cAMP
peaking at ∼51 ms and the ATP release rate (or flux) peaking at
∼157 ms after this physiological stimulus. Following the return to
full hemoglobin saturation, ATP flux returns to zero in less than
1 s. Time-dependent results using this ATP release model will be
useful when integrated into future dynamic models of microvas-
cular flow regulation based on O2-dependent ATP release from
erythrocytes.
To relate the results shown in Figure 3 to experimental measure-
ments, cAMP and ATP flux are integrated over the time required
for the desaturation step to turn on and off and for the release of
ATP to stop. It is important to recognize that our model computes
relative activation and ATP flux values for an average pathway
without considering the number of these GP-coupled pathways
present in an individual erythrocyte. Therefore, to compare our
results directly to measurements of ATP release, we normalized
our findings to agree with experimental measurements (Hanson
et al., 2009) at 15.7% sO2 ([tHb]= 0.843).
To demonstrate that predictions from our model of the ery-
throcyte ATP release pathway agree with experimental data, in
Figure 4 we plotted total ATP release vs. sO2 where the desatura-
tion magnitude [tHb]= 1−sO2. This comparison confirms that
our model captures the dependence of ATP release on sO2 under
conditions in which PDE3rel= 1. Importantly, when PDE3 activ-
ity is increased by 87% (PDE3rel= 1.87) our model predictions
of amounts of ATP released when erythrocytes are exposed to
reduce O2 closely match ATP levels measured in the presence of
FIGURE 4 | Model predictions for total ATP release vs. hemoglobin
saturation. For baseline levels of PDE3 activity, predicted ATP release
matches experimental measurements (Sprague and Ellsworth, 2012). For
an 87% increase in PDE3 activity, ATP release decreases as seen for
erythrocytes incubated in insulin (Hanson et al., 2009). Here ATP release
has been normalized so that at 15.7% sO2the model matches the ATP
release measurements without insulin.
1 nM insulin (Hanson et al., 2009). The 87% increase in PDE3
activity is based on effects of insulin on the activity of this PDE
in adipocytes (Kitamura et al., 1999). Thus, this model allows
us to predict the inhibitory effect of insulin-induced increases in
PDE3 activity on cAMP levels and ATP release from erythrocytes
in which hemoglobin saturation is reduced to 15.7% (Figure 5A).
As depicted in Figure 5B, the model also allows prediction of the
level of PDE3 activity required to replicate experimental measure-
ments of erythrocyte cAMP initiated by direct activation of Gi
with mastoparin 7 (Mas-7) in the absence and presence of PDE3-
stimulating concentrations of insulin (Hanson, 2009; Hanson
et al., 2010).
COUPLED O2-ATP TRANSPORT IN CAPILLARY NETWORKS
The simulated O2 distribution in our reconstructed capillary net-
work is shown in Figure 6A, and the 3D ATP distributions cal-
culated for O2-dependent erythrocyte ATP release in the absence
and presence of insulin are shown in Figures 6C,E, respectively.
The O2 transport model shows a nearly linear decrease in sO2
(Figure 6B) with little variation among capillaries, except for one
capillary with counter-current flow.
If the capillary inlet [ATP] (ATPin) is set to zero, all capillar-
ies for normal ATP release (blue symbols in Figure 6D) show an
increase in [ATP] although the variation among vessels is much
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FIGURE 5 | [(A), left] Model predictions for ATP release (cyan bars) and cAMP
production (purple bars) at 15.7% hemoglobin saturation vs. PDE3 activity.
[(B), right] Measured erythrocyte cAMP production (green bars) in response
to Mas-7 stimulation vs. insulin concentration (0, 1 mM, 100 nM) and model
predictions of cAMP production (purple bars) at 15.7% sO2 vs. PDE3 activity
(PDE3rel =1, 1.8, 4.1).
greater than the variation in capillary sO2. The variation in [ATP]
is due to the capillary network geometry and convective transport
of ATP combined with the degradation of ATP by ecto-ATPases.
When ATP release from erythrocytes is impaired (blue symbols
in Figure 6F), the rate of increase in [ATP] with distance down
the network is much less. The mean capillary ATP concentrations
in the absence and presence of insulin are 0.076 and 0.038µM,
respectively, implying a 50% decrease when plasma insulin is
increased to values found in pre-diabetes.
If ATPin= 0.25µM (Arciero et al., 2008), degradation of ATP
results in a decrease in capillary [ATP] until approximately
half way down the network for normal release (red symbols in
Figure 6D), and slightly further for impaired release (red symbols
in Figure 6F). In the case in which ATP release is impaired, [ATP]
nearly plateaus suggesting that the rate of release is approximately
equal to the rate of degradation. When ATP release is unim-
paired, [ATP] either plateaus or increases substantially toward
the venular end of the network. The mean ATP concentrations
in the absence and presence of insulin are 0.115 and 0.077µM,
respectively, a 33% decrease in the presence of insulin. Thus,
for either value of ATPin, there is a substantial decrease in cap-
illary ATP when low O2-induced ATP release from erythrocytes is
impaired.
Calculated values of σdilation show behavior similar to that of
mean ATP, since the length scale of signal attenuation (λ= 1 cm)
is much greater than the arterio-venous length (∼350µm) of
the capillary network. For ATPin= 0, σdilation is 1.6× 10−8 and
0.8× 10−8 for normal and impaired ATP release, respectively
(i.e., a 50% decrease), while for ATPin= 0.25µM σdilation is
2.4× 10−8 for normal vs. 1.6× 10−8 for impaired release (i.e.,
a 33% decrease).
DISCUSSION
ATP release from erythrocytes in response to both physiological
and pharmacological stimuli has been suggested to contribute to
the regulation of perfusion distribution in skeletal muscle (Ellis
et al., 2010; Sprague et al., 2010). Mechanical deformation (Wan
et al., 2008) and exposure to reduced O2 tension (Ellsworth et al.,
2009), both of which occur in small skeletal muscle microvessels,
stimulate erythrocyte ATP release. Such a mechanism provides
a means by which the distribution of perfusion can be regulated
dynamically (Ellsworth, 2000, 2004; Ellsworth et al., 2009; Pittman,
2010). Extensive experimental evidence has established that ATP
release from erythrocytes varies in response to changes in the
levels of O2 tension to which these cells are exposed (Ellsworth
et al., 1995; Jagger et al., 2001) and that increases in microvas-
cular ATP concentrations result in vasodilation that is conducted
to the feed arterioles, promoting an increase in oxygen supply
to downstream tissues (McCullough et al., 1997; Collins et al.,
1998; Ellsworth, 2000). Importantly, it has been reported that
low O2-induced ATP release and subsequent vascular responses
occur at a sufficiently fast time-scale (between 100 and 500 ms)
to allow physiologically relevant dynamic regulation of O2 sup-
ply (Dietrich et al., 2000; Wan et al., 2008; Ellis et al., 2010). In
addition, defects in O2-dependent ATP release by erythrocytes
are present in both type 2 diabetes and pre-diabetes (Sprague
et al., 2006, 2010, 2011) two disorders which are associated with
peripheral vascular disease. Taken together, these results sup-
port a role for low O2-induced ATP release from erythrocytes
in the microcirculation of skeletal muscle as a means by which
the distribution of microvascular perfusion can be dynamically
regulated (Ellsworth, 2000, 2004; Ellsworth et al., 2009; Pittman,
2010).
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FIGURE 6 | Model of steady-state oxygen-dependent ATP distribution
in capillary networks.Top two panels: calculated capillary sO2 distribution
[(A), left] in 3D network and [(B), right] as a function of distance z from
capillary entrance. Middle two panels: calculated ATP distribution for
normal ATP release [(C), left) in 3D network with ATPin = 0 and [(D), right)
as a function of z for ATPin =0 and ATPin =0.25µM. Bottom two panels:
calculated ATP distribution for impaired ATP release due to increased
plasma insulin [(E), left] in 3D network with ATPin = 0 and [(F), right) as a
function of z for ATPin =0 and ATPin =0.25µM. The color bar in (A)
indicates the variations in sO2 (17–63%) in the 3D capillary network, while
the color bars in (C,E) indicate the variations in [ATP] [0–1.6µM in (C) and
0–0.8µM in (E)] in the network.
Under normal physiological conditions,ATP release would pro-
vide an effective mechanism by which perfusion could be dynami-
cally regulated to meet tissue O2 needs. However, under conditions
in which systemic or local microvascular hematocrit is significantly
reduced, other mechanisms would be required to increase flow to
the tissue to minimize tissue hypoxia (Roy et al., 2012). Such pro-
tective mechanisms would likely be the same as those which would
become important under conditions in which low O2-induced
Frontiers in Physiology | Computational Physiology and Medicine July 2012 | Volume 3 | Article 246 | 8
Goldman et al. O2-dependent erythrocyte ATP release
ATP release from erythrocytes is defective as occurs in humans
with pre-diabetes (high insulin levels) or type 2 diabetes.
In recent years, a detailed description of microvascular O2
transport has been developed based on a number of multiscale
experimental and theoretical studies (Popel, 1989; Ellsworth et al.,
1994;Pittman, 1995, 2005, 2011; Goldman, 2008). A number of
studies have described convective and diffusive transport of O2
inside individual erythrocytes, in single capillary and arterio-
lar segments, and in arrays or networks of multiple interacting
capillaries, arterioles, and venules. A full understanding of the con-
tribution of erythrocyte-derived ATP to the regulation of blood
flow distribution in the skeletal muscle microcirculation requires
similar theoretical and experimental assessment of the release of
ATP from erythrocytes, the diffusion and binding of ATP to the
purinergic receptors on the vascular endothelium, and the impact
of conducted vasodilation initiated in the microcirculation on flow
in both individual vessels and complex vascular networks.
Here we present two experiment-based modeling components
of our evolving multiscale approach to the characterization of
the regulation of microvascular perfusion in response to low O2-
induced ATP released form erythrocytes. Most importantly, we
have a developed a novel dynamic model of the signaling path-
way within the erythrocyte that is responsible for this ATP release.
The ATP release model is based on previous experimental work
describing the components of this pathway. The predictions of
the model are consistent with reported time-scales for ATP release
(Dietrich et al., 2000; Wan et al., 2008) and agree with measured
ATP release from erythrocytes as a function of hemoglobin sO2
and hydrolysis of cAMP by PDE3. The model also predicts the
time course of ATP release, which is a vital determinant of the
effectiveness of microvascular flow regulation, and allows us to
investigate how defects in that release would compromise optimal
O2 delivery. Finally, the model can be used to predict whether cor-
rections of defects in this pathway may be important therapeutic
targets in the treatment of vascular dysfunction associated with
diseases such as pre-diabetes and type 2 diabetes in humans.
Little is known about the mechanism linking reduced hemo-
globin saturation and G-protein activation in the erythrocyte.
However, the time course used in our model for erythrocyte ATP
release is similar to the time course reported for other G-protein
activated signaling pathways. For example, dopamine activation of
a G-protein coupled potassium current (∼250 ms from activation
to increased potassium current) in the mouse midbrain (Ford et al.,
2009) and α2A adrenergic receptor activation of Gi (<100 ms) in
HEK293 cells stimulated with norepinephrine (Hein et al., 2005)
are within the time-scale modeled here for erythrocyte ATP release.
In addition to developing a model for low O2-induced ATP
release from erythrocytes, we present a model of ATP transport
in skeletal muscle capillary networks. This model incorporates a
reconstructed 3D network and is based on in vivo measurements
of rat skeletal muscle. This new approach permits the simulation
of realistic capillary ATP transport and the consequences for the
vasodilatory signal that is conducted from sites of increased O2
demand (i.e., the capillary bed) to augment blood flow. In addi-
tion, we have employed the model to enhance our understanding
of the consequences of insulin-induced decreases in erythrocyte
ATP release (measured in vitro) on conducted signaling and,
consequently, on the regulation of local O2 delivery in a realis-
tic skeletal muscle capillary network. The computational model
suggests that details of capillary network geometry and hemody-
namics are important in determining the manner in which ATP
signaling from erythrocytes is conducted upstream to regulate
microvascular O2 delivery. Importantly, the information obtained
from this capillary network model will be important for the fur-
ther development of a full multiscale description of the regulation
of microvascular O2 delivery in skeletal muscle, allowing us to
connect local tissue function (oxygen tension and consumption;
Fraser et al., 2012) with mechanisms involved in the regulation of
O2 supply.
MODEL ASSUMPTIONS AND LIMITATIONS
We modeled the O2-dependent ATP release pathway of the ery-
throcyte with a series of five biochemical steps described by four
time-dependent ordinary differential equations. Although this
model can be solved very rapidly using Matlab on a personal com-
puter, it did require inclusion of a number of parameters (∼15
rate constants and half-maximum concentrations) that have not
been directly measured. This model also requires assumptions
about how oxyhemoglobin desaturation activates Gi and how
CFTR activation opens the pannexin 1 channel leading to ATP
release. Although most of the biochemical steps used are under-
stood qualitatively and most of the constants can be estimated
from measurements of ATP release and cAMP production, one
could question the need for such a complex model. If the objective
had been only to describe existing data, then a phenomenological
model might have been adequate. However, since we were seeking
a model that could predict the detailed dynamics of ATP release
and the impact of specific changes in the pathway (e.g., increased
PDE3 activity), the complexity of the present model was necessary.
A primary assumption made in constructing our model of
intravascular ATP transport was that ATP released from erythro-
cytes into the surrounding plasma becomes well-mixed across the
vessel lumen, such that the mean plasma ATP concentration deter-
mines ATP binding to endothelial P2Y receptors. Although this may
be correct, an alternative possibility is that ATP released near the
vessel wall is more important than the mean ATP concentration. If
so, this might alter ATP action within the microvasculature as well
as other characteristics of the flow regulation system. Presently, it
is not known how ATP is radially distributed within the vascular
lumen.
There are several limitations to the present model in terms
of predicting ATP release by erythrocytes under conditions other
than those described here. First, since most parameters have
not been directly measured, their values are approximate and
may need to be revised once more detailed time-dependent data
becomes available. Second, since the relevant details of Gi activa-
tion and pannexin 1 opening are not currently known, these were
treated phenomenologically. Third, our model has ignored other
known mechanisms inducing erythrocyte ATP release including
both shear-dependent release, which appears to occur through the
same pathway, and receptor-mediated release which utilizes a dis-
tinct signaling pathway (Ellsworth and Sprague, 2012). Expansion
of this model to include these components would enhance the
robustness and utility of the current model and should enable one
www.frontiersin.org July 2012 | Volume 3 | Article 246 | 9
Goldman et al. O2-dependent erythrocyte ATP release
to predict the total time-dependent release of ATP by an erythro-
cyte that would occur in vivo under a wide range of physiological
or pathophysiological conditions.
MODEL TESTING
As described previously (Ellsworth et al., 2009), testing our full
multiscale model of blood-tissue oxygen transport and its reg-
ulation based on ATP release by erythrocytes requires in vivo
experiments. However, a large amount of development and test-
ing of individual model components will be required prior to
performing direct comparisons of model predictions to in vivo
behavior. Currently available microfluidic devices, similar to those
of Wan et al. (2008), will allow measurements of the dynamics of
O2-dependent erythrocyte ATP release enabling us to experimen-
tally test the ATP release model’s predictions under a wide range
of conditions (e.g., increased insulin). These results will provide
important dynamic information for the refinement of the model
setting the stage for further experimental testing.
MODEL PREDICTIONS AND NOVEL EXPERIMENTS
The ATP pathway model we have developed allows us to make
predictions about how the various parameters in Eqs 1–6 interact
to determine ATP release, and these predictions can be used as the
basis for novel experiments. For example, in humans with type 2
diabetes it is known that there is an approximate 40% decrease in
expression of Gi protein in the erythrocyte membrane (Sprague
et al., 2006). If we implement this in our model by decreasing
GP total accordingly in Eq. 6, we would predict a decrease in
ATP release of approximately 60% when sO2 is decreased briefly
from 100 to 15.7%. This prediction links a decrease in a known
component of the erythrocyte ATP release pathway with a known
measured outcome, i.e., reduced low O2-dependent ATP release
from erythrocytes of humans with type 2 diabetes. An attempt to
remedy this defect could be simulated in the model by decreas-
ing PDE3 activity as done experimentally with the selective PDE3
inhibitor cilostazol. Under these conditions, a 60% decrease in
PDE3 activity (PDE3rel= 0.6) would return O2-dependent ATP
release back to its normal level. Thus, the model presented here
enables us to predict the effect of a known defect in the release
pathway on ATP release, and then provides us with a mechanism
to evaluate how this defect could be most effectively remedied.
This in turn motivates new in vitro and in vivo experiments to test
these predictions in erythrocytes and in intact muscle, to deter-
mine if this approach has potential for treating humans with type
2 diabetes.
CONCLUSION
The architectural, biophysical, and temporal complexity of
microvascular O2 transport makes complete understanding of its
regulation difficult. However, it is clear that a full understanding
of the regulation of microvascular O2 delivery requires a detailed
multiscale approach. The novel theoretical models described here
for low O2-induced ATP release from erythrocytes at the intra-
erythrocyte and capillary network levels form the basis for our
dynamic systems biology model of microvascular blood flow
regulation.
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